뉴스
- Kolon crashes on TG-C failure; NGeneBio soars [K-bio pulse] Shares of three Kolon Group affiliates tumbled Tuesday after Kolon TissueGene's osteoarthritis cell and gene therapy TG-C — formerly known as Invossa &mda
- Broker Call Lifts Qurient, AbClon, L&C Bio Rebounds on Rights Offering[K-Bio Pulse] South Korea's Kosdaq market closed higher on Tuesday, supported by net buying from foreign and institutional investors, while most pharmaceutical and biotechnol
- Deepnoid and Peptron Hit Daily Limit, L&C Bio Falls on Rights Offering[K-Bio Pulse] South Korea's pharmaceutical and biotechnology sector received a boost on Aug. 3 as the KOSDAQ market posted strong gains. Buying momentum intensified, triggeri